Improvement in achievement of lipid targets in France: Comparison of data from coronary patients in the DYSIS and DYSIS II studies

被引:12
作者
Ferrieres, Jean [1 ,2 ]
Rouyer, Maja Velkovski [3 ]
Lautsch, Dominik [3 ]
Ambegaonkar, Baishali M. [3 ]
Horack, Martin [4 ]
Brudi, Philippe [3 ]
Gitt, Anselm K. [4 ,5 ]
机构
[1] Toulouse Rangueil Univ Hosp CHU, Dept Cardiol B, Toulouse, France
[2] Univ Toulouse, INSERM, UMR 1027, Dept Epidemiol & Publ Hlth, Toulouse, France
[3] Merck & Co Inc, Kenilworth, NJ USA
[4] Inst Herzinfarktforsch Forsch Ludwigshafen, Ludwigshafen, Germany
[5] Herzzentrum Ludwigshafen, Med Klin B, Kardiol, Ludwigshafen, Germany
关键词
Coronary heart disease; Ezetimibe; Hyperlipidaemia; LDL-cholesterol; Target; CLINICAL-PRACTICE; GUIDELINES;
D O I
10.1016/j.ijcard.2016.08.084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:793 / 794
页数:2
相关论文
共 9 条
[1]  
*AG FRANC SEC SAN, 2005, PRIS CHARG THER PAT
[2]   Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution [J].
Ferrieres, Jean ;
Berard, Emilie ;
Crisan, Oliviu ;
Bongard, Vanina .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (05) :302-309
[3]   PERSISTENT HIGH DISTANCE TO RECOMMENDED LDL-CHOLESTEROL-TARGETS DESPITE CHRONIC STATIN TREATMENT: RESULTS OF DYSIS [J].
Gitt, Anselm K. ;
Lautsch, Dominik ;
Ambegaonkar, Baishali ;
Horack, Martin ;
Ferrieres, Jean .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) :1934-1934
[4]   Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada [J].
Gitt, Anselm K. ;
Drexel, Heinz ;
Feely, John ;
Ferrieres, Jean ;
Gonzalez-Juanatey, Jose R. ;
Thomsen, Kristian K. ;
Leiter, Lawrence A. ;
Lundman, Pia ;
da Silva, Pedro M. ;
Pedersen, Terje ;
Wood, David ;
Juenger, Claus ;
Dellea, Pam S. ;
Sazonov, Vasilisa ;
Chazelle, Francois ;
Kastelein, John J. P. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (02) :221-230
[5]   European guidelines on cardiovascular disease prevention in clinical practice: executive summary [J].
Graham, Ian ;
Atar, Dan ;
Borch-Johnsen, Knut ;
Boysen, Gudrun ;
Burell, Gunilla ;
Cifkova, Renata ;
Dallongeville, Jean ;
De Backer, Guy ;
Ebrahim, Shah ;
Gjelsvik, Bjorn ;
Herrman-Lingen, Christoph ;
Hoes, Arno ;
Humphries, Steve ;
Knapton, Mike ;
Perk, Joep ;
Priori, Silvia G. ;
Pyorala, Kalevi ;
Reiner, Zeljko ;
Ruilope, Luis ;
Sans-Menendez, Susana ;
Reimer, Wilma Scholte op ;
Weissberg, Peter ;
Wood, David ;
Yarnell, John ;
Zamorano, Jose Luis .
EUROPEAN HEART JOURNAL, 2007, 28 (19) :2375-2414
[6]  
Kotseva K., 2016, Global heart
[7]  
Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
[8]   Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity [J].
Stamler, J ;
Daviglus, ML ;
Garside, DB ;
Dyer, AR ;
Greenland, P ;
Neaton, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (03) :311-318
[9]   Prediction of coronary heart disease using risk factor categories [J].
Wilson, PWF ;
D'Agostino, RB ;
Levy, D ;
Belanger, AM ;
Silbershatz, H ;
Kannel, WB .
CIRCULATION, 1998, 97 (18) :1837-1847